Skip to main content

Advertisement

Log in

Bone Marrow Failure and Immunodeficiency Associated with Human RAD50 Variants

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

The MRE11-RAD50-NBN (MRN) complex plays a key role in recognizing and signaling DNA double-strand breaks. Pathogenic variants in NBN and MRE11 give rise to the autosomal-recessive diseases, Nijmegen breakage syndrome (NBS) and ataxia telangiectasia-like disorder, respectively. The clinical consequences of pathogenic variants in RAD50 are incompletely understood. We aimed to characterize a newly identified RAD50 deficiency/NBS-like disorder (NBSLD) patient with bone marrow failure and immunodeficiency.

Methods

We report on a girl with microcephaly, mental retardation, bird-like face, short stature, bone marrow failure and B-cell immunodeficiency. We searched for candidate gene by whole-exome sequencing and analyzed the cellular phenotype of patient-derived fibroblasts using immunoblotting, radiation sensitivity assays and lentiviral complementation experiments.

Results

Compound heterozygosity for two variants in the RAD50 gene (p.Arg83His and p.Glu485Ter) was identified in this patient. The expression of RAD50 protein and MRN complex formation was maintained in the cells derived from this patient. DNA damage-induced activation of the ATM kinase was markedly decreased, which was restored by the expression of wild-type (WT) RAD50. Radiosensitivity appeared inconspicuous in the patient-derived cell line as assessed by colony formation assay. The RAD50R83H missense substitution did not rescue the mitotic defect in complementation experiments using RAD50-deficient fibroblasts, whereas RAD50WT did. The RAD50E485X nonsense variant was associated with in-frame skipping of exon 10 (p.Glu485_545del).

Conclusion

These findings indicate important roles of RAD50 in human bone marrow and immune cells. RAD50 deficiency/NBSLD can manifest as a distinct inborn error of immunity characterized by bone marrow failure and B-cell immunodeficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The datasets for this article are not publicly available due to concerns regarding participant/patient anonymity. Requests to access the datasets should be directed to the corresponding author.

Abbreviations

AT:

Ataxia telangiectasia

ATLD:

Ataxia telangiectasia-like disorder

DSB:

DNA double-strand break

IEI:

Inborn error of immunity

MRN:

MRE11-RAD50-NBN

NBS:

Nijmegen breakage syndrome

NBSLD:

NBS-like disorder

WES:

Whole-exome sequencing

WT:

Wild-type

References

  1. Syed A, Tainer JA. The MRE11–RAD50–NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair. Annu Rev Biochem. 2018;87:263–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kashimada A, Hasegawa S, Nomura T, Shiraku H, Moriyama K, Suzuki T, et al. Genetic analysis of undiagnosed ataxia-telangiectasia-like disorders. Brain Dev. 2019;41:150–7.

    Article  PubMed  Google Scholar 

  3. Rahman S, Canny MD, Buschmann TA, Latham MP. A survey of reported disease-related mutations in the MRE11-RAD50-NBS1 complex. Cells. 2020;9:1678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sharapova SO, Pashchenko OE, Bondarenko AV, Vakhlyarskaya SS, Prokofjeva T, Fedorova AS, et al. Geographical distribution, incidence, malignancies, and outcome of 136 eastern slavic patients with Nijmegen breakage syndrome and NBN founder variant c.657_661del5. Front Immunol. 2021;11:602482.

    Article  PubMed  PubMed Central  Google Scholar 

  5. McCarthy-Leo C, Darwiche F, Tainsky MA. DNA repair mechanisms, protein interactions and therapeutic targeting of the MRN complex. Cancers. 2022;14:5278.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet. 2009;84:605–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ragamin A, Yigit G, Bousset K, Beleggia F, Verheijen FW, Wit MY, et al. Human RAD50 deficiency: confirmation of a distinctive phenotype. Am J Med Genet. 2020;182:1378–86.

    Article  CAS  PubMed  Google Scholar 

  8. Chansel-Da Cruz M, Hohl M, Ceppi I, Kermasson L, Maggiorella L, Modesti M, et al. A disease-causing single amino acid deletion in the coiled-coil domain of RAD50 impairs MRE11 complex functions in yeast and humans. Cell Rep. 2020;33: 108559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hoshino A, Takashima T, Yoshida K, Morimoto A, Kawahara Y, Yeh T-W, et al. Dysregulation of Epstein-Barr virus infection in hypomorphic ZAP70 mutation. J Infect Dis. 2018;218:825–34.

    Article  CAS  PubMed  Google Scholar 

  10. Brandes N, Goldman G, Wang CH, Ye CJ, Ntranos V. Genome-wide prediction of disease variant effects with a deep protein language model. Nat Genet. 2023. https://doi.org/10.1038/s41588-023-01465-0. Online ahead of print.

  11. Shin B, Ahn K, Kook H, Koh J, Kang I, Lee H, et al. Overexpressed human RAD50 exhibits cell death in a p21(WAF1/CIP1)-dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ. 2001;12:243–54.

    CAS  PubMed  Google Scholar 

  12. Völkening L, Vatselia A, Asgedom G, Bastians H, Lavin M, Schindler D, et al. RAD50 regulates mitotic progression independent of DNA repair functions. FASEB J. 2020;34:2812–20.

    Article  PubMed  Google Scholar 

  13. Schröder-Heurich B, Wieland B, Lavin MF, Schindler D, Dörk T. Protective role of RAD50 on chromatin bridges during abnormal cytokinesis. FASEB J. 2014;28:1331–41.

    Article  Google Scholar 

  14. Bender CF, Sikes ML, Sullivan R, Huye LE, Le Beau MM, Roth DB, et al. Cancer predisposition and hematopoietic failure in Rad50 S/S mice. Genes Dev. 2002;16:2237–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Delia D, Mizutani S, Panigone S, Tagliabue E, Fontanella E, Asada M, et al. ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes. Br J Cancer. 2000;82:1938–45.

    CAS  PubMed  Google Scholar 

  16. Roth S, Rottach A, Lotz-Havla AS, Laux V, Muschaweckh A, Gersting SW, et al. Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production. Nat Immunol. 2014;15:538–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, et al. Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles. J Allergy Clin Immunol. 2013;131:1437–40.

    Article  PubMed  Google Scholar 

  18. Wolska-Kuśnierz B, Gregorek H, Chrzanowska K, Piątosa B, Pietrucha B, Heropolitańska-Pliszka E, et al. Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options – a retrospective analysis. J Clin Immunol. 2015;35:538–49.

    Article  PubMed  Google Scholar 

  19. Luo G, Yao MS, Bender CF, Mills M, Bladl AR, Bradley A, et al. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A. 1999;96:7376–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Adelman CA, De S, Petrini JHJ. Rad50 is dispensable for the maintenance and viability of postmitotic tissues. Mol Cell Biol. 2009;29:483–92.

    Article  CAS  PubMed  Google Scholar 

  21. Demuth I, Frappart P-O, Hildebrand G, Melchers A, Lobitz S, Stöckl L, et al. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet. 2004;13:2385–97.

    Article  CAS  PubMed  Google Scholar 

  22. Shimada H, Shimizu K, Mimaki S, Sakiyama T, Mori T, Shimasaki N, et al. First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Hum Genet. 2004;115:372–6.

    Article  PubMed  Google Scholar 

  23. Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Stinson BM, Loparo JJ. Repair of DNA double-strand breaks by the nonhomologous end joining pathway. Annu Rev Biochem. 2021;90:137–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lee J-H, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene. 2007;26:7741–8.

    Article  CAS  PubMed  Google Scholar 

  26. Daniel JA, Pellegrini M, Lee J-H, Paull TT, Feigenbaum L, Nussenzweig A. Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J Cell Biol. 2008;183:777–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Hohl M, Mojumdar A, Hailemariam S, Kuryavyi V, Ghisays F, Sorenson K, et al. Modeling cancer genomic data in yeast reveals selection against ATM function during tumorigenesis. PLoS Genet. 2020;16: e1008422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Pellegrini M, Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L, et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature. 2006;443(7108):222–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mika Nagase and Girmay Asgedom for their technical assistance, Louisa Weinhold and Katja Bezjak for scientific assistance, Detlev Schindler for support with large T immortalized cell lines and Axel Schambach for support in setting up the lentiviral complementation system.

Funding

This study was supported by the Research on Measures for Intractable Disease Project to SK, the Claudia von Schilling Foundation for Breast Cancer Research to TD, and MEXT/JSPS KAKENHI (Grant Number: 22K07887) to HK.

Author information

Authors and Affiliations

Authors

Contributions

MT designed and performed experiments and analyzed the data. AH, KB, JR, HLM, IF, DT, XY and JK performed experiments and analyzed the data. NS provided the patient data. KY, SM and SO performed genetic analysis. MT, AH, TD and HK wrote the manuscript. SK and TM provided critical discussion. TD and HK conceptualized the study. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Thilo Dörk or Hirokazu Kanegane.

Ethics declarations

Ethics Approval

This study was performed in line with the principles of the Helsinki Declaration. Approval was granted by the Tokyo Medical and Dental University Ethics Committee (protocol no. 103).

Consent to Participate

Informed consent was obtained from the patient and her parents.

Consent for Publication

Informed consent was obtained from the patient and her parents.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Thilo Dörk and Hirokazu Kanegane share senior authorship.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 2777 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takagi, M., Hoshino, A., Bousset, K. et al. Bone Marrow Failure and Immunodeficiency Associated with Human RAD50 Variants. J Clin Immunol 43, 2136–2145 (2023). https://doi.org/10.1007/s10875-023-01591-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-023-01591-8

Keywords

Navigation